Registration holders of Pharmaceutical Products for human and veterinary use (manufacturers and importers) are directed to submit antimicrobials batch production / Import data (finished formulations) for use within Pakistan regularly in DRIS. DRAP will be analyzing yearly data for regulatory purposes. The data is critical for use in implementing Antimicrobial Stewardship Policies to combat AMR in Pakistan.
- Minutes of 93rd meeting of Medical Devices Board
- S.R.O. 1587(I)/2025 DRAP has adopted Pharmaceutical Inspection Co-operation Scheme (PIC/S) guidelines